NSE - Delayed Quote INR
SENORES PHARMACEUTICALS L (SENORES.NS)
517.05
-15.45
(-2.90%)
At close: April 25 at 3:29:55 PM GMT+5:30
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Swapnil Jatinbhai Shah | MD & Director | -- | -- | 1985 |
| Mr. Deval Rajnikant Shah | Whole-Time Director & CFO | -- | -- | 1963 |
| Mr. Chetan Bipinchandra Shah | Whole-Time Director & COO | -- | -- | 1966 |
| Mr. Hanuwant Singh Shaktawat | Assistant Vice President of HR & Admin | -- | -- | -- |
| Mr. Vinay Kumar Mishra | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Deepak Jain | Vice President of Regulatory Affairs | -- | -- | -- |
SENORES PHARMACEUTICALS L
1101 To 1103, 11th floor
South Tower ONE 42 opposite Jayantilal Park Ambali Bopal Road
Ahmedabad, 380054
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 113
Description
Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
Corporate Governance
SENORES PHARMACEUTICALS L’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
MARKSANS.NS Marksans Pharma Limited
216.03
-5.40%
DSNKY Daiichi Sankyo Company, Limited
24.85
+0.44%
NVS Novartis AG
112.14
+0.87%
AMGN Amgen Inc.
280.84
+0.36%
GILD Gilead Sciences, Inc.
103.17
-2.81%
NVO Novo Nordisk A/S
62.08
-0.88%
BMY Bristol-Myers Squibb Company
47.90
-1.62%
MRK Merck & Co., Inc.
82.74
+3.63%
PFE Pfizer Inc.
22.92
+0.61%
LLY Eli Lilly and Company
884.54
+2.89%